We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

64 hedge funds and large institutions have $89.3M invested in PDS Biotechnology in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

480% more capital invested

Capital invested by funds: $15.4M → $89.3M (+$73.9M)

380% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $2.51M

257% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 7

90% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 10

36% more funds holding

Funds holding: 47 → 64 (+17)

5.72% more ownership

Funds ownership: 18.2% → 23.92% (+5.7%)

Holders
64
Holders Change
+17
Holders Change %
+36.17%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
19
Reduced
10
Closed
7
Calls
$12.1M
Puts
$2.51M
Net Calls
+$9.54M
Net Calls Change
+$7.73M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$3.18M
2
EI
EAM Investors
California
+$2.33M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.29M
4
Morgan Stanley
Morgan Stanley
New York
+$1.47M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.4M

Top Sellers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
-$810K
2
Citadel Advisors
Citadel Advisors
Florida
-$648K
3
Renaissance Technologies
Renaissance Technologies
New York
-$529K
4
NLVP
New Leaf Venture Partners
New York
-$348K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$171K
Name Holding Trade Value Shares
Change 		Change in
Stake
Connor, Clark & Lunn Investment Management (CC&L)
26
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$366K +$196K +27,727 New
Bank of America
27
Bank of America
North Carolina
$363K -$15.7K -2,222 -7%
Citadel Advisors
28
Citadel Advisors
Florida
$359K -$648K -91,795 -77%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$351K +$188K +26,592 New
Wells Fargo
30
Wells Fargo
California
$335K -$2.61K -370 -1%
JF
31
Jump Financial
Illinois
$319K +$170K +24,130 New
TI
32
Trexquant Investment
Connecticut
$318K +$170K +24,108 New
AA
33
ALPS Advisors
Colorado
$256K +$137K +19,367 New
6CM
34
683 Capital Management
New York
$254K +$136K +19,280 New
TCWM
35
Total Clarity Wealth Management
Illinois
$226K +$121K +17,109 New
SCA
36
Sassicaia Capital Advisers
New York
$185K +$98.8K +14,000 New
Charles Schwab
37
Charles Schwab
California
$175K +$93.7K +13,278 New
AFM
38
Andesa Financial Management
Pennsylvania
$165K -$88.2K -12,500 -50%
Simplex Trading
39
Simplex Trading
Illinois
$154K +$82.7K +11,724 New
LIP
40
Lighthouse Investment Partners
Florida
$148K +$78.9K +11,190 New
Man Group
41
Man Group
United Kingdom
$145K +$77.5K +10,988 New
EWA
42
EP Wealth Advisors
California
$135K +$1.46K +207 +2%
Group One Trading
43
Group One Trading
Illinois
$128K +$67.7K +9,599 +9,599%
QT
44
Quantbot Technologies
New York
$89.8K +$48K +6,804 New
Rockefeller Capital Management
45
Rockefeller Capital Management
New York
$45K +$24.1K +3,413 New
TRCT
46
Tower Research Capital (TRC)
New York
$30K -$82.7K -11,717 -84%
FWA
47
Freedom Wealth Alliance
Wisconsin
$29.2K +$15.6K +2,211 New
CSPIA
48
Cary Street Partners Investment Advisory
Virginia
$28.1K +$15K +2,131 New
US Bancorp
49
US Bancorp
Minnesota
$27.5K – – –
Osaic Holdings
50
Osaic Holdings
Arizona
$13K +$14 +2 +0.2%
1
2
3

PDSB Hedge Fund Activity: Q4 2022 in Review

64 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q4 2022, worth a combined $89.3M — up 480% from $15.4M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PDSB positions and 7 closed out — a net gain of 18 holders — while 19 added to existing stakes and 10 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $3.18M. The largest seller was LPL Financial, cutting an estimated $810K.

  • 64 institutional investors held PDS Biotechnology (PDSB) as of Q4 2022, up from 47 in Q3 2022.
  • Funds reported $89.3M of PDS Biotechnology stock for Q4 2022, up 480% quarter-over-quarter.
  • 25 funds opened new PDS Biotechnology positions in Q4 2022 and 7 closed out, a net change of +18 holders.
  • The largest PDS Biotechnology buyer in Q4 2022 was Millennium Management, an estimated $3.18M added.
  • The largest PDS Biotechnology seller in Q4 2022 was LPL Financial, an estimated $810K sold.

Based on aggregated 13F filings for Q4 2022.